InvestSMART

Osteopore Limited (ASX:OSX)

ALERT: Price-sensitive ASX Announcement for OSX
Current share price for OSX : $0.005 -0.002 (-28.57%)+
Announcement
Release
26 Mar 2026 6:35PM
Price at Release
$0.007
Full Release
download
Summary
Osteopore Limited, a Singapore-founded regenerative medicine company specializing in 3D-printed biomimetic and bioresorbable implants, has announced a further drawdown as part of their subscription agreement with Advance Opportunities Fund. The company will issue 4.0% redeemable convertible notes totaling A$20,000,000, divided into four tranches. The latest announcement details the subscription of additional sub-tranches of T2 Notes, amounting to A$250,000. These funds will support ongoing business activities and future development opportunities.
Key Points
  • Osteopore Limited is a leader in 3D-printed biomimetic and bioresorbable implants.
  • The company entered into a subscription agreement with Advance Opportunities Fund and Advance Opportunities Fund I.
  • Intends to issue 4.0% redeemable convertible notes with a total nominal value of A$20,000,000.
  • Notes are divided into four tranches of A$5,000,000 each, further divided into 20 equal sub-tranches.
  • Subscribers have subscribed for additional sub-tranches of T1 and T2 Notes.
  • Funds raised will be used for business operations and future projects.
  • Announced subscription for a further sub-tranche of T2 Notes, worth A$250,000.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.